Outcomes of Cardiac Repair in Heterotaxy Syndrome Patients-Tertiary Center Experience

异位综合征患者心脏修复的预后——三级中心经验

阅读:2

Abstract

BACKGROUND: This study aims to determine factors associated with poor outcomes and frequency of arrhythmia incidence in patients with heterotaxy syndrome (HS). METHODS: A retrospective cohort study in a single tertiary center was conducted and included patients with operated HS between 2011 and 2020. A total of 52 patients were included. Relevant factors associated with mortality that were considered included univentricular (UV) or biventricular (BV) physiology, prematurity, low weight/age at surgery, the presence of atrioventricular valve regurgitation, anomalous pulmonary veins drainage, and type of atrial isomerism. RESULTS: Thirty-three patients (63.4%) were diagnosed with left atrial isomerism (LAI), whereas the remaining 19 (36.5%) were diagnosed with right atrial isomerism (RAI). Thirty-eight patients (73%) underwent UV repair, whereas 14 patients (27%) had BV physiology. Patients were followed up for an average of 4.8 years. Lastly, 14 patients (27%) had died during the follow-up period. Notably, most patients with complete repair are among the LAI group, and high-grade heart block only occurred in patients with LAI. Moreover, patients with LAI were more likely to receive BV repair, whereas patients with RAI were more likely to undergo UV repair (P = 0.008). In addition, pulmonary venous anomalies occurred more frequently among the RAI group. Expectedly, nonsinus rhythm was frequently present among the cohort. Finally, the mortality rate was significantly higher among the RAI group (42% vs 18%, P = 0.06). CONCLUSION: Managing HS patients with UV physiology still remains a challenge. Risk factors for mortality included lower initial operation age, and RAI approached significance. These data may assist with risk stratification and patient counseling.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。